Director Insights and Analytics
NewAmsterdam Pharma
Director Insights and Analytics
NewAmsterdam Pharma
Biopharma developing LDL-C lowering CETP therapies
Job Description:
Director, Insights & Analytics
NewAmsterdam Pharma is an innovative biotech company with the experience and expertise to deliver across its ambitious clinical, regulatory, and commercial goals. Our robust scientific approach focuses on advancing a new era of life-saving treatments for lipid-related diseases. Our vision is that people at risk for heart disease can take control of their health and live longer, fuller lives. Our team is led by a world-class team of industry veterans and key opinion leaders, including some of the world’s preeminent cardiometabolic experts and we foster a passionate, supportive culture that is backed by a high level of integrity and inclusivity.
The Director is accountable for developing and communicating actionable insights that shape brand strategy and tactics by leveraging a range of primary and secondary market research techniques. The role will partner with all functions supporting the U.S. and global launch, including Marketing, Managed Markets, Medical, Operations, and Finance, as well as NAP’s global partner, to provide key insights that enable insight-driven decisions. The role will report to the Senior Director, Insights & Analytics.
The position is responsible for building and managing a comprehensive insights-generation plan to address the key business questions facing the brand team. This plan will include primary and secondary market research across various stakeholders, data analysis, tracking, and reporting.
The Director will also be expected to advise and partner with various levels of management in support of products and corporate initiatives. The role therefore requires a high degree of business acumen, strong collaboration and interdependent partnering skills, and the ability to work independently in support of company priorities. Experience in a product launch or retail market is a plus.
Major Responsibilities:
Requirements:
Salary and Benefits:
We offer a competitive base salary, annual bonus, and long-term incentives. In addition, we provide a comprehensive benefits package, including health insurance, dental and vision coverage, term life and disability coverage, and retirement plans.
NewAmsterdam Pharma is an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to sex, gender identity or expression, sexual orientation, marital status, race, color, national origin, ancestry, ethnicity, religion, age, veteran status, disability, genetic information, or any other basis protected by federal, state or local law.
Biopharma developing LDL-C lowering CETP therapies
NewAmsterdam Pharma develops oral therapies for cardiometabolic diseases and runs late-stage clinical programs around obicetrapib, a CETP inhibitor aimed at lowering LDL-cholesterol in high-risk cardiovascular disease patients. Its pipeline includes a fixed-dose combo of obicetrapib and ezetimibe in Phase 2 (ROSE2) and three Phase 3 trials (BROADWAY, BROOKLYN, and PREVAIL) to evaluate obicetrapib in HeFH, ASCVD, and as a cardiovascular outcomes trial. Founded in 2019 and based in Naarden, the Netherlands, the company focuses on transforming lipid management and cardiovascular risk reduction through targeted CETP inhibition.
Explore more opportunities at NewAmsterdam Pharma